Lamictal cd and Depakote drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lamictal cd (lamotrigine) and Depakote (divalproex sodium). Common drug interactions include rash among females and type 2 diabetes mellitus among males.

The phase IV clinical study analyzes what interactions people have when they take Lamictal cd and Depakote. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Lamictal cd?

Lamictal cd has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 1,228 Lamictal cd users. Check the latest studies of Lamictal cd.

What is Depakote?

Depakote has active ingredients of divalproex sodium. It is often used in bipolar disorder. eHealthMe is studying from 55,581 Depakote users. Check the latest studies of Depakote.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 23, 2026

32 people who take Lamictal cd and Depakote together, and have interactions are studied.

Lamictal cd and Depakote drug interactions.

What are the common drug interactions of Lamictal Cd and Depakote, by gender? *:

female:

  1. Rash
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Acne (skin problems that cause pimples)
  4. Alanine aminotransferase increased
  5. Ammonia increased
  6. Anxiety
  7. Aphthous stomatitis (mouth ulcer)
  8. Aspartate aminotransferase increased
  9. Blood bilirubin increased
  10. Blood cholesterol increased

male:

  1. Type 2 diabetes mellitus
  2. Vision blurred
  3. Impaired fasting glucose
  4. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  5. Muscular weakness (muscle weakness)
  6. Neuropathy peripheral (surface nerve damage)
  7. Pneumonia
  8. Pulmonary sarcoidosis (growth of tiny collections of inflammatory cells in lungs)
  9. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
  10. Rash

What are the common drug interactions of Lamictal Cd and Depakote, by age (0-1 to 60+)? *:

0-1:

  1. Haematocrit decreased
  2. Hydrocephalus (water on the brain)
  3. Impaired healing
  4. Joint dislocation (a joint position is changed from normal position)
  5. Nephrolithiasis (calculi in the kidneys)
  6. Skin discolouration (change of skin colour)
  7. Talipes
  8. Abdominal distension
  9. Corneal opacity (scarring or clouding of the cornea)
  10. Dermatitis diaper (diaper rash is a common form of inflamed skin)

2-9:

  1. Alanine aminotransferase increased
  2. Ammonia increased
  3. Aspartate aminotransferase increased
  4. Blood bilirubin increased
  5. Central auditory processing disorder (cannot process the information they hear in the same way as others do)
  6. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  7. Dysarthria (speech disorder)
  8. Fatigue (feeling of tiredness)
  9. Rash
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

10-19:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Aggression
  3. Drug level decreased
  4. Drug toxicity
  5. Dysstasia (difficulty in standing)
  6. Mania (a state of abnormally elevated or irritable mood)
  7. Rash
  8. Screaming (a long loud piercing cry)
  9. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  10. Weight increased

20-29:

  1. Acne (skin problems that cause pimples)
  2. Alopecia (absence of hair from areas of the body)
  3. Blood cholesterol increased
  4. Blood triglycerides increased
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  7. Diplopia (double vision)
  8. Drug ineffective
  9. Ill-defined disorder
  10. Rash

30-39:

  1. Anxiety
  2. Aphthous stomatitis (mouth ulcer)
  3. Depression
  4. Dizziness
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Pain in extremity
  7. Rash
  8. Rash erythematous (redness of the skin)
  9. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

40-49:

  1. Type 2 diabetes mellitus
  2. Abdominal pain upper
  3. Chest pain
  4. Diabetes with hyperosmolarity (diabetes with increasing blood glucose levels and dehydration)
  5. Diabetic foot
  6. Dyslipidaemia (abnormal amount of lipids)
  7. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  8. Hepatitis c
  9. Hypertriglyceridaemia (excess of triglycerides in the blood)
  10. Impaired fasting glucose

50-59:

  1. Skin ulcer
  2. Vulvovaginal pruritus (vulvovaginal severe itching)

60+:

  1. Confusional state
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Ill-defined disorder
  4. Insomnia (sleeplessness)
  5. Leukopenia (less number of white blood cells in blood)
  6. Platelet count increased
  7. Psychotic disorder
  8. Purpura (purplish discoloration of the skin)
  9. Rash
  10. Stupor (lack of critical cognitive function and level of consciousness)

What are the existing conditions these people have? *

  1. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 9.38%
  2. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 6.25%
  3. Depression: 2 people, 6.25%
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 6.25%
  5. Affective Disorder (mental disorder): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Lamictal cd and Depakote?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lamictal cd and Depakote:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lamictal cd:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Depakote:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lamictal cd and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Depakote and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lamotrigine and divalproex sodium (the active ingredients of Lamictal cd and Depakote, respectively), and Lamictal cd and Depakote (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: